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Persistent strains of Theiler’s virus, a murine picornavirus, produce a life-long infection of the central nervous system of
the mouse and induce a chronic demyelinating disease. Strain DA1, a molecular clone of such a persistent strain, produces
a prominent cytopathic effect in BHK-21 cells but is less efficient at infecting L929 cells. We cloned the cDNA of a derivative
of virus DA1, adapted to promote a rapid cytopathic effect in L929 cells. Adaptation of the new variant (named KJ6) to L929
cells correlated with an enhanced viral entry rather than with an increased replication rate of the genome. Mutations
responsible for L929 cells adaptation occurred in amino acids exposed at the surface of the capsid, in the CD loop of VP1
(100–102) and in the EF loop of VP2 (162–171–173), suggesting that these residues could be involved in receptor recognition.
These two clusters of amino acids are precisely known to be part of neutralization epitopes. They also differentiate persistent
from neurovirulent strains of Theiler’s virus. Adaptation of the virus to L929 cells was accompanied by attenuation of its
virulence for the mouse. Taken together, these data suggest a close relationship between receptor binding, virus neutral-
ization, and virus phenotype. © 1998 Academic Press
INTRODUCTION
Theiler’s murine encephalomyelitis virus (TMEV) is a
naturally occurring pathogen of the mouse belonging to
the Picornaviridae family (Theiler, 1937). The various
TMEV isolates are generally classified in two subgroups
on the basis of the pathology they induce in susceptible
mice (Theiler and Gard, 1940; for reviews, see Rodriguez
et al., 1987; Brahic et al., 1991).
Neurovirulent strains, such as GDVII, replicate permis-
sively into neurons and cause an acute lethal polioen-
cephalomyelitis. Persistent strains, including strains DA
and BeAn, cause a biphasic disease of the central ner-
vous system of susceptible mice (Lipton, 1975). The early
disease is characterized by a mild encephalitis during
which the virus essentially infects the neurons of the
brain. Later, the virus is mainly found in the spinal cord,
first in the gray and then in the white matter, and causes
a persistent infection. Persistence of the virus is associ-
ated with a strong inflammatory response and lesions of
primary demyelination.
Although they cause markedly different pathologies,
neurovirulent and persistent strains of TMEV are closely
related and share about 95% identity at the amino acid
sequence level (Pevear et al., 1987, 1988; Ohara et al.,
1988; Michiels et al., 1995). Both viruses replicate per-
missively in BHK-21 cells, wherein they produce a rapid
complete cytopathic effect. However, the two strains be-
have differently with respect to L929 cells infection.
Whereas the GDVII strain is as cytopathic for L929 cells
as for BHK-21 cells, virus DA only causes a slow cyto-
pathic effect in L929 cells. Infection with 1 plaque-form-
ing unit (PFU) per cell of virus DA1 generally provokes a
complete cytopathic effect in BHK-21 cells 48 h after
infection. In L929 cells, areas of rounded cells extend
progressively over time and complete cytopathic effect
requires about 1 week.
In this work, we observed that adaptation of virus DA1
to produce a rapid cytopathic effect in L929 cells corre-
lated with an improved rate of spread of the infection
from cell to cell. Adaptation to L929 cells occurred
through mutations of amino acids exposed at the surface
of the viral capsid and likely to interact with the cellular
receptor. Interestingly, these mutations, which were se-
lected in the absence of selection by the immune sys-
tem, modified two clusters of amino acids which are
known to be part of neutralizing epitopes. Adaptation of
the virus to L929 cells decreased its ability to persist in
the central nervous system of the mouse.
RESULTS
Adaptation of the DA1 virus to L929 cells
Although virus DA1 can infect L929 cells, its propaga-
tion in these cells is restricted and the resulting cyto-
pathic effect is very slow. In order to select a virus
adapted to promote a rapid and complete cytopathic
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effect in L929 cells, the DA1 strain was passaged repeat-
edly on these cells. After 25 successive passages, we
obtained a virus stock able to induce a complete cyto-
pathic effect 3 days after infection instead of more than
1 week afterward, as observed for the parental strain. We
cloned the cDNA of an adapted virus out of this stock.
Therefore, total RNA was extracted from the culture su-
pernatant of cells infected for 3 days with the cytopathic
variant. On the basis of (unpublished) results obtained
with other variants of the virus, we postulated that mu-
tations responsible for adaptation to L929 cells occurred
in the capsid-encoding region. Thus, we amplified, by
RT–PCR, the fragment encoding the capsid of the virus
adapted to L929 cells. This fragment was then used to
replace the corresponding region of pTMDA1, as de-
scribed under the Materials and Methods section. Four
cDNA clones were isolated in this way. The viruses
obtained from these clones were tested for their relative
ability to promote a cytopathic effect on L929 cells. One
of these clones was not infectious. Viruses produced
from two other cDNA clones caused a complete cyto-
pathic effect 3 days after infection.
The last virus, named KJ6 (from clone pKJ6), killed L929
cells within 24 h of infection (Fig. 1).
Characterization of virus KJ6
Adaptation of the virus to L929 cells could be due
either to an enhanced replication rate of the virus or to an
improved cell-to-cell propagation of the virions. We first
analyzed whether the genomes of viruses KJ6 and DA1
replicated with different efficiencies in L929 cells. RNAs
transcribed in vitro from pTMDA1 and pKJ6 were trans-
fected into L929 and BHK-21 cells by electroporation.
Total RNA was extracted from cells at 4, 10, and 24 h
after transfection, and viral genome replication was fol-
lowed by dot blot hybridization using a virus-specific
radiolabeled probe (Fig. 2).
FIG. 1. Cytopathic effect promoted by viruses DA1 and KJ6 on L929 cells. L929 cells were infected at a MOI of 5 PFU per cell with the DA1 virus
or the KJ6 variant. Twenty-four hours after infection, a complete cytopathic effect was observed with the KJ6 variant but only a few rounded cells
appeared at this time when infected with the DA1 strain.
FIG. 2. Replication and propagation of KJ6 and DA1 viruses. In vitro
transcribed RNAs from pTMDA1 and pKJ6 were transfected by electropo-
ration into L929 and BHK-21 cells. The evolution of the amount of viral RNA
in the culture was monitored by dot blot hybridization and quantified by
use of a PhosphorImager. The curves show the evolution of the amount of
viral RNA as a function of time (h) in L929 (top) and BHK-21 cells (bottom).
Ten hours after transfection, secondary infections are not yet detectable
and the amount of RNA thus reflects the replication rate of the genome. At
later times, the signal also depends on the rate of propagation of the
infection to untransfected cells. Two independent experiments were done
from which similar conclusions could be drawn.
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Ten hours after transfection, before the detection of viral
RNA from secondary infections, no difference was detected
between replication levels of the two viruses, either in L929
cells or in BHK-21 cells. Hence, adaptation of the virus to
L929 cells did not appear to result from a difference in
replication ability. From 24 h after transfection, a clear dif-
ference occurred, in L929 cells, between the amounts of
RNA of KJ6 and DA1. This difference is likely due to a higher
cell-to-cell propagation rate for KJ6 in these cells.
Replication of the genome of viruses DA1 and KJ6 in
L929 cells was also compared by following the kinetics
of virus production, after transfection of the viral genome
in these cells (Fig. 3). For both viruses, infectious parti-
cles were detected from 8 h after transfection and the
amounts of viruses produced were similar. This confirms
the data from dot blot experiments and shows that the
genomes of the two viruses replicate with comparable
efficiencies and kinetics in L929 cells.
Since the transfection experiments rule out the possi-
bility that a difference of replication level could account
for the adaptation of virus KJ6 to L929 cells, we com-
pared the efficiencies with which extracellular virions
initiate the infection of the cells (infectivity). For this
purpose, we compared the number and size of plaques
produced by either virus in BHK-21 and L929 cells (Fig.
4). In BHK-21 cells, plaques produced by virus KJ6 were
slightly smaller than those produced by virus DA1. Sur-
prisingly, in L929 cells, virus KJ6, which is much more
cytopathic, also produced plaques smaller than those of
virus DA1. Interestingly, a given KJ6 virus suspension
produced 10 times more plaques in L929 cells than in
BHK-21 cells, suggesting that adaptation of KJ6 to L929
cells occurred through improvement of viral entry.
To confirm the enhanced infectivity of KJ6, we infected
L929 cells and, as a control, BHK-21 cells with DA1 and
KJ6 viruses at a multiplicity of infection (MOI) of 5 PFU
per cell. Ten hours after infection, before the detection of
secondary infections, the percentage of infected cells
was measured by immunocytochemistry, using an anti-
VP1 monoclonal antibody (Fig. 5 and Table 1). The pro-
portion of BHK-21 cells infected by the two viruses was
equivalent. In L929 cells, the proportion of infected cells
was markedly higher for the KJ6 variant than for virus
DA1. This confirms the enhanced infectivity of KJ6 for
L929 cells, which likely correlates with a higher affinity of
the KJ6 capsid for the receptor present on these cells.
Identification of mutations involved in adaptation
We sequenced the 2660 nucleotide BsiWI-BamHI frag-
ment differing between pKJ6 and pTMDA1. Six mutations
occurred between the two viruses (Table 2). They affect
amino acids clustered in two regions of the capsid. Two
mutations occurred in VP1 (Gly 100 2. Asp, and Thr 102
FIG. 3. Kinetics of the replication of DA1 and KJ6 in L929 cells. RNAs transcribed in vitro from pTMDA1 and pKJ6 plasmids were transfected in L929
cells by electroporation. Culture supernatant was collected 4, 6, 8, and 12 h after transfection and assayed for the presence of infectious viral particles
by plaque assay on BHK-21 cells. The values shown on the graph are the means and standard deviations of three independent experiments.
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FIG. 4. Plaques produced by KJ6 and DA1 viruses on L929 and BHK-21 cells. The same virus suspensions (either KJ6 or DA1) were used to infect
BHK-21 and L929 cells.
FIG. 5. Efficiency of viral entry detected by immunocytochemistry. BHK-21 and L292 cells were infected with viruses KJ6 and DA1 at a MOI of 5 PFU
per cell. At 10 h postinfection, infected cells (stained dark) were detected by immunocytochemistry.
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2. Ala). Four mutations occurred in VP2, one of which
did not affect the amino acid sequence (Gly 162 2. Ser,
Ser 171 2. Gly, Thr 173 2. Ile, and Phe 256 2. Phe).
Since these mutations increase the efficiency of viral
entry into cells, they might affect amino acids involved in
virus–receptor interaction.
Effect of the mutations on pathogenicity
Some of the mutations that led to adaptation of the
virus to L929 cells affect amino acids that were shown to
differ between strains of persistent and neurovirulent
phenotypes (Michiels et al., 1995; Luo et al., 1996; Zhou
et al., 1997). Furthermore, one of these mutations (VP2-
162, Gly 2. Ser) corresponded to a DA1 to GDVII mu-
tation. We thus wondered whether virus KJ6 could have
acquired an enhanced neurovirulence. In order to eval-
uate the biological importance of the mutations in vivo,
nine 3-week-old SJL/J mice were infected intracerebrally
with 104 PFU of virus KJ6. Eight days, 3 weeks, and 6
weeks after infection, mice were sacrificed and exam-
ined for the presence of inflammation and viral antigen in
the central nervous system by immunohistochemistry.
Infection of susceptible mice with virus DA1 generally
results in a mild encephalitis lasting the first 2 weeks
after inoculation. At this stage, the virus is mainly found
in the neurons of the brain and (to a lesser extent) of the
spinal cord. During the chronic phase of the disease, the
virus is almost exclusively detected in the white matter of
the spinal cord. Viral antigen is associated with an im-
portant inflammatory reaction and with primary demyeli-
nation (Brahic et al., 1981; Aubert et al., 1987).
The disease caused by virus KJ6 was clearly attenuated
compared with that produced by the DA1 strain. Eight days
after infection, only few cells positive for viral antigen were
found in the brain or spinal cord. Twenty-one and forty-five
days postinfection, some positive cells associated with a
mild inflammation were detected in the white matter of the
spinal cord. However, the amount of viral antigen and the
extent of inflammation were clearly lower than what was
generally observed for virus DA1 (data not shown).
In order to gain a more quantitative comparison of the
persistence of KJ6 and DA1, we quantified, by dot blot,
the amount of viral RNA present in the brain and spinal
cord of FVB mice infected for 45 days with either virus. As
shown in Fig. 6, viral RNA was readily detected in the
spinal cord of mice infected with the DA1 strain while it
was almost undetectable in mice infected with virus KJ6.
Thus, mutations which strongly enhance the propaga-
tion of the virus in mouse cells in vitro clearly attenuate
the virulence in vivo.
DISCUSSION
We adapted virus DA1 to produce a rapid cytopathic
effect in L929 cells. By rescuing the capsid-encoding
region of the virus population adapted to grow on L929
cells, we obtained a recombinant virus, named KJ6,
which induces a prominent cytopathic effect in these
cells. Upon transfection in L929 cells, the genome of
virus KJ6 did not replicate better than the genome of virus
DA1. In contrast, infection of L929 cells by virus KJ6 was
much more efficient than infection by virus DA1. This
strongly suggests that mutations responsible for adap-
tation of the virus to L929 cells enhanced viral entry
rather than replication. This is in agreement with the fact
that mutations in the capsid-encoding region were suffi-
cient to allow for adaptation of the virus to L929 cells.
The three-dimensional structure of the capsid of three
Theiler’s virus strains have previously been determined
by X-ray crystallography (strain DA, Grant et al., 1992;
strain BeAn, Luo et al., 1992; strain GDVII, Luo et al.,
1996). Mutations accounting for adaptation to L929 cells
are clustered in two loops exposed at the surface of the
capsid. Residues 100 and 102 of VP1 are at the top of the
CD loop, which is the outermost loop of the capsid.
Residues 162, 171, and 173 of VP2 are part of the EF loop
(or ‘‘puff B’’) of this protein (Grant et al., 1992). All these
amino acids are particularly surface-exposed and are
thus very accessible for binding a cell receptor or for
neutralization by antibodies.
It has been suggested, by analogy to the rhinovirus
canyon, that the receptor might contact the GH loop of
VP3, in the bottom of a depression (‘‘pit’’) found in Thei-
ler’s virus and in Mengo virus capsids. In the case of
Mengovirus, alteration of the VP3 GH loop by a modifi-
cation of pH resulted in loss of infectivity, supporting the
hypothesis of a direct contact between the receptor and
the pit (Kim et al., 1990). In the case of Theiler’s virus,
TABLE 1
Percentage of BHK-21 and L929 Cells, Positive for Viral Antigen,
10 h after Infection with 5 PFU of Viruses KJ6 and DA1a
Virus DA1 Virus KJ6
L929 18.2 6 1.5 89.7 6 1.9
BHK-21 51.5 6 5.2 50.5 6 3.2
a Values are the means of four experiments 6 standard deviations.
TABLE 2
Position of Mutated Nucleotides and Corresponding Amino Acids
in pKJ6 and pTMDA1
Position pTMDA1 pKJ6
VP2 - 162 Glycine (GGT) Serine (AGT)
VP2 - 171 Serine (AGC) Glycine (GGC)
VP2 - 173 Threonine (ACC) Isoleucine (ATC)
VP2 - 256 Phenylalanine (TTC) Phenylalanine (TTT)
VP1 - 100 Glycine (GGT) Asparagine (GAT)
VP1 - 102 Threonine (ACC) Alanine (GCC)
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there is no experimental indication of any such interac-
tion and we believe that the surface amino acids identi-
fied in this study are part of the receptor/coreceptor
binding site. By comparing the structures predicted for
the capsids of persistent and neurovirulent strains, Zhou
et al., (1997) also came to the conclusion that a gap
formed by the EF loop of VP2 (puff B) and the CD loop of
VP1, at the surface of virus DA, could participate in
receptor recognition. This is not necessarily contradic-
tory to the pit hypothesis since the receptor could con-
tact both the bottom and the rim of the depression.
Alternatively, the bottom of the pit could contact the
receptor while surface loops could be involved in the
recognition of coreceptors responsible for the modula-
tion of target cell specificity.
These clusters of amino acids in VP1 and VP2 also
correspond to the sites of the capsid exhibiting the most
significant structural variations between persistent and
neurovirulent isolates of the virus (Michiels et al., 1995;
Luo et al., 1996; Zhou et al., 1997). In persistent strains,
the mutations of these loops turned out to attenuate viral
persistence. DA viruses with mutations in amino acid
VP1-101 were significantly attenuated in both the acute
and the chronic phases of the disease. (Zurbriggen et al.,
1989; 1991; Wada et al., 1994). In the EF loop of VP2,
mutations in amino acids 141 or 173 have also been
found to affect viral persistence (Jarousse et al., 1994,
1996; Sato et al., 1996). Accordingly, in our study, viru-
lence of virus KJ6 for the mouse was clearly attenuated
compared to that of the wild-type strain.
Consistent with the data presented in this study, we
found (manuscript in preparation) that other mutations
affecting the surface of the capsid and notably the CD
loop of VP1 affect the tropism of Theiler’s virus in vitro
and within the central nervous system of the mouse.
Our current hypothesis is that the receptor or the
receptor/coreceptor complex differs slightly on various
cell types and that the capsids of the different viruses
FIG. 6. Persistence of viral RNA in brain and spinal cord. (A) Detection, by dot blot, of viral RNA in the brain (BR) and spinal cord (SC) of six mice
infected for 45 days with viruses DA1 and KJ6 and in two uninfected mice (2). (B) Quantification, by PhosphorImager, of the dot blot shown in A. Black
columns, viral RNA in brain; hatched columns, viral RNA in spinal cords.
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have different affinities for these receptor complexes.
This would explain subtle differences observed in the
tropism and phenotype of closely related viral strains.
Interestingly, the mutations adapting the virus to L929
cells, which were obtained in vitro in the absence of any
immune selection, precisely affect two clusters of amino
acids known to be part of neutralizing epitopes. Indeed,
viral mutants selected to escape neutralization by mono-
clonal antibodies were shown to be mutated either in
amino acid VP1-101 (Zurbriggen et al., 1989) or in amino
acids 141, 163, and 173 of VP2 (Sato et al., 1996).
It is probable that the region corresponding to major
neutralization epitopes also contributes to the formation
of the viral receptor binding site. Similar hypotheses
have been proposed for Poliovirus and FMDV, related
genera of the Picornavirus family (Courderc et al., 1994;
Pavio et al., 1996).
MATERIALS AND METHODS
Virus production and cell culture
Plasmid pTMDA1 is a pBluescript derivative carrying
the full-length cDNA of Theiler’s virus, strain DA (Daniels
et al., 1952). This plasmid is a clonal derivative of plasmid
pTMDA (McAllister et al., 1989) which turned out to be a
mixture of at least two slightly different sequences. In
vitro transcription of pTMDA1 from the T7 promoter to a
unique ClaI site yields an RNA corresponding to the
genome of TMEV, which is infectious upon transfection
in permissive cell lines.
Plasmid pKJ6 was obtained by replacing, in pTMDA1,
the capsid-encoding region by that of a variant virus
adapted to grow in L929 cells. The recombinant virus
(KJ6) produced from pKJ6 is highly cytopathic for L929
cells.
For virus production from cDNA clones, plasmids
pTMDA1 and pKJ6 were linearized with ClaI restriction
enzyme, and transcribed in vitro using T7 RNA polymer-
ase (Boehringer-Mannheim). In vitro transcribed RNAs
were then transfected in BHK-21 cells by electroporation.
Viruses were collected from the supernatant of trans-
fected cells after completion of the cytopathic effect.
Viruses were titrated by standard plaque assay in
BHK-21 cells.
BHK-21 and L929 cells (from ATCC) were cultured as
described previously (Michiels et al., 1997).
Obtention and cloning of the adapted DA variant
Virus DA1 was passaged on L929 cells until a variant
virus population promoting rapid cytopathic effect emerged.
Total RNA was extracted from the culture supernatant of
infected cells using the method of Chomczynski and Sacchi
(1987). cDNA was synthesized, after oligo(dt) priming,
by AMV reverse transcriptase (USB), for 90 min at 45°C.
The viral capsid-encoding region was amplified by
PCR using primers TM107 (59 - CGC CCA TGC ACA CGA
GCA TTC - 39) and TM127 (59 - AGC GCC TCT GTA
GGG AAG CCA - 39). Pfu polymerase (Stratagene) was
used to minimize mutations introduced by the PCR
procedure.
The amplified capsid-encoding region was cloned as
a 2660-bp BsiWI-BamHI fragment to replace the corre-
sponding region of pTMDA1. Viral RNAs transcribed in
vitro from four such cDNA clones were transfected into
BHK-21 and L929 cells to assess infectivity. Viruses pro-
duced were then tested for their cytopathic effect on
L929 cells.
The sequence of the 2660-bp BsiWI-BamHI region of
clone pKJ6 was determined on both strands, using T7
DNA polymerase (Sequenase, USB). Sequencing reac-
tions were generally done on single-stranded DNA ob-
tained from subfragments cloned in phagemids pTZ18R
and pTZ19R (Pharmacia).
Transfection of cells and dot blot hybridization
BHK-21 and L929 cell monolayers were trypsinized,
washed twice, and resuspended in ice-cold phosphate
buffered saline (PBS). Cells were then transfected by
electroporation with up to 20 mg of RNA transcribed in
vitro from pTMDA1 or pKJ6. Electroporation was per-
formed using an Easyject1 electroporator (Equibio) at
1500 V (3750 V/cm), 25 mF, 2310 ohms. Cells were then
resuspended in culture medium and split into several
6-cm petri dishes. At 4, 10, and 24 h after transfection,
total RNA was extracted from transfected cells by the
method of Chomczynski and Sacchi (1987) and the
amount of viral RNA was monitored by dot blot hybrid-
ization as described previously (Michiels et al., 1997) and
analyzed with a PhosphorImager (Molecular Dynamics).
Immunocytochemistry
L929 and BHK-21 cells were infected with the DA1 or
KJ6 virus at a multiplicity of infection of 5 PFU per cell.
Ten hours after infection, cells were fixed for 20 min in 4%
paraformaldehyde in PBS. Viral antigen was then de-
tected as described previously (Michiels et al., 1997),
using an anti-VP1 monoclonal antibody (F12B3, kindly
provided by M. Brahic).
Mice infections
Three-week-old female SJL/J mice were infected intra-
cerebrally with 104 PFU of KJ6 virus. The brains and
spinal cords were collected from groups of three mice at
8, 21, and 45 days after inoculation. Viral antigen was
detected in paraffin sections by immunohistochemistry,
essentially as described by Brahic et al. (1984).
For dot blot analysis, 3-week-old female FVB mice
were infected intracerebrally with 104 PFU of DA1 or KJ6
virus. One out of seven mice infected with virus KJ6 died
3 weeks after infection for unknown reasons. In view of
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the consistent data obtained for all the other mice, this
mouse was not investigated further. Forty-five days after
infection, total RNA was extracted from brains and spinal
cords collected from six mice infected with each virus
and from two uninfected age-matched mice. Viral RNA
was quantified by dot blot hybridization.
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